People: Aslan Pharmaceuticals Ltd (ASLN.OQ)

ASLN.OQ on NASDAQ Stock Exchange Global Market

15 Nov 2019
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sun, Chin-Feng 

Mr. Chin-Feng Sun (also named Qingfeng Sun) has been serving as Independent Director in ASLAN Pharmaceuticals Limited since April 15, 2016. He holds a Master of Business Administration from University of Michigan, the United States, and a Master's degree in Materials Science from Wayne State University, the United States. He is also Independent Director in TWi Pharmaceuticals, Inc., TAH TONG TEXTILE CO., LTD. and Wonderful Hi-Tech Co., Ltd., Chairman of the Board in FiTek Photonics Corporation, two investment companies and another company, Director in Signax Technology Capital Inc., LYTONE ENTERPRISE, INC., a development company and another investment company, as well as General Manager in SAGA UNITEK VENTURES.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --